INFU
InfuSystems Holdings Inc
NYSE MKT: INFU · HEALTHCARE · MEDICAL DEVICES
$10.13
+3.05% today
Updated 2026-04-30
Market cap
$215.27M
P/E ratio
34.39
P/S ratio
1.50x
EPS (TTM)
$0.31
Dividend yield
—
52W range
$5 – $11
Volume
0.1M
InfuSystems Holdings Inc (INFU) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$10.13
12-Month target
$11.63
2030 Target
—
Intrinsic (DCF)
$15.03
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 4.62%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.